
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-07-06-2016
- Volume 11
- Issue 7
Vessel Improves Dissolution Test Results
A vessel for the Hanson Research Vision G2 series of dissolution testers is designed to provide more consistent vessel-to-vessel dissolution test results.
The Hanson Super Precision Vessel (Hanson SPV) from Hanson Research, designed for the Vision G2 series of dissolution testers, has a closer conformance to an ideal vessel shape to provide more consistent vessel-to-vessel dissolution test results in USP Apparatus 2, the company reports.
The development is based on the company’s work with standard-precision versus super-precision vessels in the SR8-Plus series of dissolution testers, an experience that has corroborated the findings of investigators within the industry indicating vessel quality is a significant factor in obtaining consistent and repeatable results in USP Apparatus 2.
The Hanson SPV resolves issues relating to routine calibration of dissolution testing equipment, whether by chemical calibration using USP Prednisone Reference Standard tablets, by enhanced mechanical calibration (EMC) according to industry standards such as ASTM E2503-13, or by a pharmaceutical company’s own in-house protocols.
The vessel is available in 1-liter vessel capacities, clear or amber, for the SR8-Plus, Vision G2 Classic 6, and Vision G2 Elite 8 dissolution testers.
Source:
Articles in this issue
over 9 years ago
Potential Consequences of the CDMO Acquisition Bingeover 9 years ago
Flow Chemistry Discoveries Advance Continuous Processingover 9 years ago
Excipient Quality Essentialsover 9 years ago
CordenPharma Expands Service Offeringsover 9 years ago
Real-time Monitoring Systems for Drug Shipmentsover 9 years ago
Pump Designed for Continuous Processing Scale-upover 9 years ago
Juniper Pharma Services Adds Tablet Pressover 9 years ago
Recipharm Expands Serialization Capabilitiesover 9 years ago
Charles River Acquires Blue Stream LaboratoriesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




